Black Diamond Therapeutics Inc. (BDTX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Black Diamond Therapeutic...

    NASDAQ: BDTX · Real-Time Price · USD
    2.94
    0.07 (2.44%)
    At close: Sep 05, 2025, 3:59 PM
    2.94
    0.00%
    After-hours: Sep 05, 2025, 07:42 PM EDT

    Black Diamond Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 343K 437K 3.24M 2.22M
    Gross Profit
    		 -343K -437K -3.24M -2.22M
    Operating Income
    		 -78.78M -86.46M -92.83M -126.87M
    Interest Income
    		 2.18M 1.92M 2.03M 3.46M
    Pretax Income
    		 -69.68M -82.44M -91.17M -125.6M
    Net Income
    		 -69.68M -82.44M -91.17M -125.6M
    Selling & General & Admin
    		 27.47M 27.11M 28.39M 30.04M
    Research & Development
    		 51.31M 58.91M 64.44M 96.83M
    Other Expenses
    		 -3.29M n/a n/a n/a
    Operating Expenses
    		 75.49M 86.02M 92.83M 126.87M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 75.84M 86.46M 92.83M 126.87M
    Income Tax Expense
    		 n/a n/a -4.4M -2.39M
    Shares Outstanding (Basic)
    		 55.03M 43.95M 36.33M 36.19M
    Shares Outstanding (Diluted)
    		 55.03M 43.95M 36.33M 36.19M
    EPS (Basic)
    		 -1.27 -1.88 -2.51 -3.47
    EPS (Diluted)
    		 -1.27 -1.88 -2.51 -3.47
    EBITDA
    		 -69.33M -86.02M -92.32M -126.67M
    EBIT
    		 -69.68M -86.46M -92.83M -126.87M
    Depreciation & Amortization
    		 343K 437K 508K 205K

    Add to Watchlist